Neurexin-neuroligin signaling in synapse development

Current Opinion in Neurobiology

Volumn 17, Issue 1, 2007, Pages 43-52

  Craig, Ann Marie ^a   Kang, Yunhee ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NEUROXIN; CELL ADHESION MOLECULE; GLUTAMIC ACID; NEUREXIN; NEUROLIGIN; NEUROLOGIN 1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; CELL DIFFERENTIATION; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 33846867244     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2007.01.011     Document Type: Review

References (66)

1. Ushkaryov Y.A., Petrenko A.G., Geppert M., and Sudhof T.C. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 257 (1992) 50-56
2. Scheiffele P., Fan J., Choih J., Fetter R., and Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 (2000) 657-669
3. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., and Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119 (2004) 1013-1026. Using co-cultures of neurons with COS cells expressing neurexins, this study showed that signaling occurs from neurexins to the postsynaptic site to mediate clustering of receptors and scaffolding proteins through neuroligins. In contrast to prior work focusing on glutamate synapses, these authors showed that neurexin signaling occurs at GABA synapses selectively through neuroligin 2.
4. Prange O., Wong T.P., Gerrow K., Wang Y.T., and El-Husseini A. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci USA 101 (2004) 13915-13920. These authors altered the levels of neuroligin 1 and PSD-95 in cultured neurons and showed that the ratio of these proteins affects not only glutamate synapses but also GABA synapses. For example, increased expression of PSD-95 not only enhanced glutamate-mediated transmission but also reduced GABA-mediated input. Thus, the level of neuroligins and key interacting partners can control the balance of glutamate versus GABA inputs on a neuron.
5. Chih B., Engelman H., and Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307 (2005) 1324-1328. This study followed on key earlier work [2] showing that presentation of neuroligins to glutamatergic axons is sufficient to induce presynaptic differentiation. Here, overexpression and knockdown of neuroligins in cultured neurons was reported to alter glutamatergic and GABAergic inputs. The major functional effect of knockdown of neuroligins 1, 2 and 3 together was a reduction in mIPSC-like events.
6. Tabuchi K., and Sudhof T.C. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 79 (2002) 849-859
7. Rudenko G., Nguyen T., Chelliah Y., Sudhof T.C., and Deisenhofer J. The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell 99 (1999) 93-101
8. Ferns M.J., Campanelli J.T., Hoch W., Scheller R.H., and Hall Z. The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans. Neuron 11 (1993) 491-502
9. ••], this is one of a series of recent studies that explored the functional effects of alternative splicing of neurexins. This study reported that addition of the site 4 insert to neurexin 1β selectively reduces binding to neuroligin 1 and reduces clustering of neuroligins 1/3/4 and PSD-95 in the co-culture assay, but maintains high-affinity binding to neuroligin 2 and clustering of neuroligin 2 and gephyrin. Thus, β-neurexin +S4 variants might be selective for GABAergic synapses, and -S4 variants selective for glutamatergic synapses.
10. Sheckler L.R., Henry L., Sugita S., Sudhof T.C., and Rudenko G. Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing. J Biol Chem 281 (2006) 22896-22905
11. Nguyen T., and Sudhof T.C. Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J Biol Chem 272 (1997) 26032-26039
12. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34 (2003) 27-29
13. Andres C., Beeri R., Friedman A., Lev-Lehman E., Henis S., Timberg R., Shani M., and Soreq H. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. Proc Natl Acad Sci USA 94 (1997) 8173-8178
14. Dong H., Xiang Y.Y., Farchi N., Ju W., Wu Y., Chen L., Wang Y., Hochner B., Yang B., Soreq H., et al. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci 24 (2004) 8950-8960
15. Comoletti D., Flynn R., Jennings L.L., Chubykin A., Matsumura T., Hasegawa H., Sudhof T.C., and Taylor P. Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta. J Biol Chem 278 (2003) 50497-50505
16. Dean C., Scholl F.G., Choih J., DeMaria S., Berger J., Isacoff E., and Scheiffele P. Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 6 (2003) 708-716
17. Geppert M., Khvotchev M., Krasnoperov V., Goda Y., Missler M., Hammer R.E., Ichtchenko K., Petrenko A.G., and Sudhof T.C. Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. J Biol Chem 273 (1998) 1705-1710
18. Ullrich B., Ushkaryov Y.A., and Sudhof T.C. Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 14 (1995) 497-507
19. Sugita S., Saito F., Tang J., Satz J., Campbell K., and Sudhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154 (2001) 435-445
20. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418 (2002) 422-425
21. A receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 11 (1999) 4457-4462
22. Levi S., Grady R.M., Henry M.D., Campbell K.P., Sanes J.R., and Craig A.M. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci 22 (2002) 4274-4285
23. Missler M., Hammer R.E., and Sudhof T.C. Neurexophilin binding to alpha-neurexins. A single LNS domain functions as an independently folding ligand-binding unit. J Biol Chem 273 (1998) 34716-34723
24. Beglopoulos V., Montag-Sallaz M., Rohlmann A., Piechotta K., Ahmad M., Montag D., and Missler M. Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination. Mol Cell Biol 25 (2005) 7278-7288
25. Hata Y., Davletov B., Petrenko A.G., Jahn R., and Sudhof T.C. Interaction of synaptotagmin with the cytoplasmic domains of neurexins. Neuron 10 (1993) 307-315
26. Hata Y., Butz S., and Sudhof T.C. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci 16 (1996) 2488-2494
27. Biederer T., and Sudhof T.C. Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem 275 (2000) 39803-39806
28. Grootjans J.J., Reekmans G., Ceulemans H., and David G. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. J Biol Chem 275 (2000) 19933-19941
29. Irie M., Hata Y., Takeuchi M., Ichtchenko K., Toyoda A., Hirao K., Takai Y., Rosahl T.W., and Sudhof T.C. Binding of neuroligins to PSD-95. Science 277 (1997) 1511-1515
30. Iida J., Hirabayashi S., Sato Y., and Hata Y. Synaptic scaffolding molecule is involved in the synaptic clustering of neuroligin. Mol Cell Neurosci 27 (2004) 497-508
31. Meyer G., Varoqueaux F., Neeb A., Oschlies M., and Brose N. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 47 (2004) 724-733
32. Varoqueaux F., Jamain S., and Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 83 (2004) 449-456
33. Song J.Y., Ichtchenko K., Sudhof T.C., and Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci USA 96 (1999) 1100-1105
34. Rosales C.R., Osborne K.D., Zuccarino G.V., Scheiffele P., and Silverman M.A. A cytoplasmic motif targets neuroligin-1 exclusively to dendrites of cultured hippocampal neurons. Eur J Neurosci 22 (2005) 2381-2386
35. Levinson J.N., Chery N., Huang K., Wong T.P., Gerrow K., Kang R., Prange O., Wang Y.T., and El-Husseini A. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. J Biol Chem 280 (2005) 17312-17319
36. Fu Z., Washbourne P., Ortinski P., and Vicini S. Functional excitatory synapses in HEK293 cells expressing neuroligin and glutamate receptors. J Neurophysiol 90 (2003) 3950-3957
37. Sara Y., Biederer T., Atasoy D., Chubykin A., Mozhayeva M.G., Sudhof T.C., and Kavalali E.T. Selective capability of SynCAM and neuroligin for functional synapse assembly. J Neurosci 25 (2005) 260-270
38. Nam C.I., and Chen L. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc Natl Acad Sci USA 102 (2005) 6137-6142
39. Dean C., and Dresbach T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 29 (2006) 21-29
40. Levinson J.N., and El-Husseini A. Building excitatory and inhibitory synapses: balancing neuroligin partnerships. Neuron 48 (2005) 171-174
41. Missler M., and Sudhof T.C. Neurexins: three genes and 1001 products. Trends Genet 14 (1998) 20-26
42. Rowen L., Young J., Birditt B., Kaur A., Madan A., Philipps D.L., Qin S., Minx P., Wilson R.K., Hood L., et al. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 79 (2002) 587-597
43. ••], this study explored the functional effects of alternative splicing of neurexins and neuroligins. The authors reported that addition of the site 4 insert to β-neurexins selectively inhibits binding to +B neuroligin 1 but maintains high-affinity binding to -B neuroligins. α-Neurexins also bind specifically to -B neuroligins. Splicing at the neuroligin A site did not regulate binding to neurexins.
44. ••], this study explored the functional effects of alternative splicing of neurexins and neuroligins. These authors showed that addition of the B insert to neuroligin 1 reduced its ability to recruit GABAergic terminals in a neuron overexpression assay and increased its targeting to glutamatergic synapses. The effect of the B insert occurs by reduced binding to +S4 β-neurexin. Addition of the A insert to neuroligins was reported to increase targeting to GABAergic synapses and promote function of these synapses by unknown mechanisms.
45. Patzke H., and Ernsberger U. Expression of neurexin Ialpha splice variants in sympathetic neurons: selective changes during differentiation and in response to neurotrophins. Mol Cell Neurosci 15 (2000) 561-572
46. Missler M., Zhang W., Rohlmann A., Kattenstroth G., Hammer R.E., Gottmann K., and Sudhof T.C. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 424 (2003) 939-948
47. A receptors, reduced levels of synaptic vesicle proteins and a slight reduction in the ratio of VGAT puncta to VGlut puncta, but clustering of the scaffolding proteins PSD-95 and gephyrin was normal.
48. Zhang W., Rohlmann A., Sargsyan V., Aramuni G., Hammer R.E., Sudhof T.C., and Missler M. Extracellular domains of alpha-neurexins participate in regulating synaptic transmission by selectively affecting N- and P/Q-type Ca2+ channels. J Neurosci 25 (2005) 4330-4342
49. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17 (1996) 9-19
50. Okabe S., Miwa A., and Okado H. Spine formation and correlated assembly of presynaptic and postsynaptic molecules. J Neurosci 21 (2001) 6105-6114
51. Gerrow K., Romorini S., Nabi S.M., Colicos M.A., Sala C., and El-Husseini A. A preformed complex of postsynaptic proteins is involved in excitatory synapse development. Neuron 49 (2006) 547-562
52. Craig A.M., Graf E.R., and Linhoff M.W. How to build a central synapse: clues from cell culture. Trends Neurosci 29 (2006) 8-20
53. Biederer T., Sara Y., Mozhayeva M., Atasoy D., Liu X., Kavalali E.T., and Sudhof T.C. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297 (2002) 1525-1531
54. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., and Greenberg M.E. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103 (2000) 945-956
55. Wang C.Y., Chang K., Petralia R.S., Wang Y.X., Seabold G.K., and Wenthold R.J. A novel family of adhesion-like molecules that interacts with the NMDA receptor. J Neurosci 26 (2006) 2174-2183
56. Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H., Kaang B.K., and Kim E. SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses. Neuron 50 (2006) 233-245
57. Kim S., Burette A., Chung H.S., Kwon S.K., Woo J., Lee H.W., Kim K., Kim H., Weinberg R.J., and Kim E. NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat Neurosci 9 (2006) 1294-1301
58. Chih B., Afridi S.K., Clark L., and Scheiffele P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 13 (2004) 1471-1477
59. Comoletti D., De Jaco A., Jennings L.L., Flynn R.E., Gaietta G., Tsigelny I., Ellisman M.H., and Taylor P. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 24 (2004) 4889-4893
60. Chubykin A.A., Liu X., Comoletti D., Tsigelny I., Taylor P., and Sudhof T.C. Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem 280 (2005) 22365-22374
61. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74 (2004) 552-557
62. Yan J., Oliveira G., Coutinho A., Yang C., Feng J., Katz C., Sram J., Bockholt A., Jones I.R., Craddock N., et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 10 (2005) 329-332
63. Vincent J.B., Kolozsvari D., Roberts W.S., Bolton P.F., Gurling H.M., and Scherer S.W. Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. Am J Med Genet B Neuropsychiatr Genet 129 (2004) 82-84
64. Gauthier J., Bonnel A., St-Onge J., Karemera L., Laurent S., Mottron L., Fombonne E., Joober R., and Rouleau G.A. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet 132 (2005) 74-75
65. Blasi F., Bacchelli E., Pesaresi G., Carone S., Bailey A.J., and Maestrini E. Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 220-221
66. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J Mol Graph 14 33-38 (1996) 27-38